Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Femur Infiltration: A Feature That Predict Bone Complications in Gaucher Disease. Re-Assessing Bone Marrow Involvement through Machine Learning

Marcio M Andrade-Campos, Esther Valero-Tena, Jose Verdu-Diaz, Jordi Diaz-Manera, Isidro Arevalo-Vargas, Irene Serrano-Gonzalo, Mercedes Roca-Espiau, Pilar Giraldo

Blood (2022) 140 (Supplement 1): 2605–2606.

https://doi.org/10.1182/blood-2022-158444

Published: 2022

Journal Articles

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Nieves Garcia-Gisbert, Brayan Merchan, Sara Garcia-Avila, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Marcio M Andrade-Campos, Ramon M. Pujol, Leonor Arenillas, Xavier Calvo, Carles Besses, Antonio Salar, Beatriz Bellosillo

Blood (2021) 138 (Supplement 1): 2599.

https://doi.org/10.1182/blood-2021-148297

Published: 2021

Journal Articles

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Marcio M Andrade-Campos, MD PhD, Lierni Fernández-Ibarrondo, Joan Gibert, PhD, Concepción Fernández, Brayan Merchan, MD, Nieves García Gisbert, BSc, Laura Camacho, Leonor Arenillas, MD PhD, Sara García Ávila, MD, Raquel Longarón, Antonio Salar, MD PhD, Carles Besses, MD PhD, Beatriz Bellosillo, PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-142705

Published: 2020

Journal Articles

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Marcio M Andrade-Campos, MD PhD, Laura Lopez de Frutos, PhD, Jorge J Cebolla, MSc, Blanca Medrano-Engay, PhD, Mercedes Roca-Espiau, PhD, Beatriz Gomez-Barrera, David Iniguez, Pilar Giraldo, PhD

Blood (2019) 134 (Supplement_1): 2323.

https://doi.org/10.1182/blood-2019-122347

Published: 2019

Journal Articles

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

Marcio M Andrade-Campos, MD PhD, Antonio Salar, MD PhD, Blanca Sanchez-Gonzalez, MD, Concepción Fernández-Rodríguez, Eva Gimeno, MD PhD, L Ruiz, Gabriel Piquer, Francesc Garcia-Pallarols, BSc, Natalia Papaleo, MD, Ivonne Vazquez, Lluís Colomo, MD PhD, Beatriz Bellosillo, PhD

Blood (2019) 134 (Supplement_1): 492.

https://doi.org/10.1182/blood-2019-131081

Published: 2019

Journal Articles

Twenty-Five Years Diagnosing Gaucher’s Disease in Spain, What We Have Learned?

Marcio M Andrade-Campos, PhD, Jose L Capablo, PhD, Jesus J Fraile, PhD, Mercedes Roca-Espiau, PhD, Pilar Irun, PhD, Jorge J Cebolla, MSc, Laura Lopez de Frutos, PhD, Izaskun Arenaz, MSci, Jesus Villarrubia, PhD, Abelardo Barez, PhD, Horacio Cano, MD, Teresa Molero, PhD, Lucia Villalon, PhD, Pilar Giraldo, PhD

Blood (2018) 132 (Supplement 1): 1110.

https://doi.org/10.1182/blood-2018-99-115474

Published: 2018

Journal Articles

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Marcio M Andrade-Campos, PhD, Jorge J Cebolla, MSc, Laura Lopez de Frutos, PhD, Pilar Irun, PhD, Soledad Noya, MD, Santiago Nieto, MD, Lucia Villalon, PhD, Ana I Arribas, MD, Abelardo Barez, PhD, Javier Garcia-Frade, PD, Maria Lourdes Hermosin, MD, Jesús-María Hernández-Rivas, MD PhD, Daiana Ibarretxe, MD, Maria L Lozano, MD PhD, Teresa Molero, PhD, Maria Angeles Perez-Saenz, MDPhD, Jesus Villarrubia, PhD, Pilar Giraldo, PhD

Blood (2018) 132 (Supplement 1): 4942.

https://doi.org/10.1182/blood-2018-99-115534

Published: 2018

NARROW

Femur Infiltration: A Feature That Predict Bone Complications in Gaucher Disease. Re-Assessing Bone Marrow Involvement through Machine Learning

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

Twenty-Five Years Diagnosing Gaucher’s Disease in Spain, What We Have Learned?

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Email alerts

ASH Publications

American Society of Hematology

Femur Infiltration: A Feature That Predict Bone Complications in Gaucher Disease. Re-Assessing Bone Marrow Involvement through Machine Learning

Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes

Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms

Computational Analysis Model Applied to Spanish Gaucher Registry Data

Assessment of Cell-Free DNA (cfDNA) in 221 Patients with Lymphoproliferative Malignancies at Diagnosis and during Follow-up

Twenty-Five Years Diagnosing Gaucher’s Disease in Spain, What We Have Learned?

Prospective National-Base Multicenter Study to Standardize the Follow-up of Type 1Gaucher Disease Patients Treated with Eliglustat Under Standard of Care Practice. Trazelga Project

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only